The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe?

Toxicon

Volumn 56, Issue 7, 2010, Pages 1186-1192

  de Bernard, Marina ^a,b   D'Elios, Mario M ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Helicobacter pylori; HP NAP; Immune modulation; Immunotherapy; Inflammation; Th1 Th2

Indexed keywords

B7 ANTIGEN; BACTERIAL PROTEIN; BACTERIOFERRITIN; BETA2 INTEGRIN; CD86 ANTIGEN; GAMMA INTERFERON; HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYELOPEROXIDASE; OXYGEN RADICAL; PLASMINOGEN ACTIVATOR INHIBITOR 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOPLASTIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME RELEASE; HELICOBACTER PYLORI; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFLAMMATION; LEUKOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOMODULATION; MICE; MONOCYTES; NEUTROPHIL ACTIVATION; TH1 CELLS;

HELICOBACTER PYLORI;

EID: 77957905503     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2009.09.020     Document Type: Review

References (55)

1. Amedei A., Cappon A., Codolo G., Cabrelle A., Polenghi A., Benagiano M., Tasca E., Azzurri A., D'Elios M.M., Del Prete G., de Bernard M. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J. Clin. Invest. 2006, 116:1092-1101.
2. Atherton J.C. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol. 2006, 1:63-96.
3. Bamford K.B., Fan X., Crowe S.E., Leary J.F., Gourley W.K., Luthra G.K., Brooks E.G., Graham D.Y., Reyes V.E., Ernst P.B. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998, 114:482-492.
4. Blaser M.J., Chen Y., Reibman J. Does Helicobacter pylori protect against asthma and allergy?. Gut 2008, 57:561-567.
5. Brisslert M., Enarsson K., Lundin S., Karlsson A., Kusters J.G., Svennerholm A.M., Backert S., Quiding-Järbrink M. Helicobacter pylori induce neutrophil transendothelial migration: role of the bacterial HP-NAP. FEMS Microbiol. Lett. 2005, 249:95-103.
6. Ceci P., Cellai S., Falvo E., Rivetti C., Rossi G.L., Chiancone E. DNA condensation and self-aggregation of Escherichia coli Dps are coupled phenomena related to the properties of the N-terminus. Nucleic Acids Res. 2004, 32:5935-5944.
7. Ceci P., Mangiarotti L., Rivetti C., Chiancone E. The neutrophil-activating Dps protein of Helicobacter pylori, HP-NAP, adopts a mechanism different from Escherichia coli Dps to bind and condense DNA. Nucleic Acids Res. 2007, 35:2247-2256.
8. Codolo G., Mazzi P., Amedei A., Del Prete G., Berton G., D'Elios M.M., de Bernard M. The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell. Microbiol. 2008, 10:2355-2363.
9. Codolo G., Amedei A., Steere A.C., Papinutto E., Cappon A., Polenghi A., Benagiano M., Paccani S.R., Sambri V., Del Prete G., Baldari C.T., Zanotti G., Montecucco C., D'Elios M.M., de Bernard M. Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum. 2008, 58:3609-3617.
10. Colombo M.P., Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 2002, 13:155-168.
11. Cooksley C., Jenks P.J., Green A., Cockayne A., Logan R.P., Hardie K.R. NapA protects Helicobacter pylori from oxidative stress damage and its production is influenced by the ferric uptake regulator. J. Med. Microbiol. 2003, 52:461-469.
12. Davies G.R., Banatvala N., Collins C.E., Sheaff M.T., Abdi Y., Clements L., Rampton D.S. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand. J. Gastroenterol. 1994, 29:419-424.
13. Del Giudice G., Covacci A., Telford J.L., Montecucco C., Rappuoli R. The design of vaccines against Helicobacter pylori and their development. Annu. Rev. Immunol. 2001, 19:523-563.
14. Del Prete G., Chiumiento L., Amedei A., Piazza M., D'Elios M.M., Codolo G., de Bernard M., Masetti M., Bruschi F. Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein. J. Allergy Clin. Immunol. 2008, 122:908-913.
15. D'Elios M.M., Del Prete G. Th1/Th2 balance in human disease. Transplant. Proc. 1998, 30:2373-2377.
16. D'Elios M.M., Manghetti M., De Carli M., Costa F., Baldari C.T., Burroni D., Telford J.L., Romagnani S., Del Prete G. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 1997, 158:962-967.
17. D'Elios M.M., Amedei A., Cappon A., Codolo G., Del Prete G., de Bernard M. The neutrophil activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol. Med. Microbiol. 2007, 50:157-164.
18. D'Elios M.M., Codolo G., Amedei A., Mazzi P., Berton G., Zanotti G., Del Prete G., de Bernard M. Helicobacter pylori, asthma and allergy. FEMS Immunol. Med. Microbiol. 2009, 56:1-8.
19. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996, 20:1161-1181.
20. Dundon W.G., Nishioka H., Polenghi A., Papinutto E., Zanotti G., Montemurro P., Del Giudice G., Rappuoli R., Montecucco C. The neutrophil-activating protein of Helicobacter pylori. Int. J. Med. Microbiol. 2002, 291(6-7):545-550.
21. Evans D.J., Evans D.G., Takemura T., Nakano H., Lampert H.C., Graham D.Y., Granger D.N., Kvietys P.R. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 1995, 63:2213-2220.
22. Gamble J.R., Harlan J.M., Klebanoff S.J., Vadas M.A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:8667-8671.
23. Gonzalo J.A., Lloyd C.M., Kremer L., Finger E., Martinez-A C., Siegelman M.H., Gutierrez-Ramos J.C. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 1996, 98:2332-2345.
24. Goodwin C.S. Helicobacter pylori gastritis, peptic ulcer, and gastric cancer: clinical and molecular aspects. Clin. Infect. Dis. 1997, 25:1017-1019.
25. Hamlet A., Thoreson A.C., Nilsson O., Svennerholm A.M., Olbe L. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers. Gastroenterology 1999, 116:259-268.
26. Kottakis F., Papadopoulos G., Pappa E.V., Cordopatis P., Pentas S., Choli-Papadopoulou T. Helicobacter pylori neutrophil-activating protein activates neutrophils by its C-terminal region even without dodecamer formation, which is a prerequisite for DNA protection - novel approaches against Helicobacter pylori inflammation. FEBS J. 2008, 275:302-317.
27. Kranzer K., Eckhardt A., Aigner M., Knoll G., Deml L., Speth C., Lehn N., Rehli M., Schneider-Brachert W. Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect. Immun. 2004, 72:4416-4423.
28. Laudanna C., Kim J.Y., Constantin G., Butcher E. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 2002, 186:37-46.
29. Lehmann F.S., Terracciano L., Carena I., Baeriswyl C., Drewe J., Tornillo L., De Libero G., Beglinger C. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G481-G488.
30. Li X., Pal U., Ramamoorthi N., Liu X., Desrosiers D.C., Eggers C.H., Anderson J.F., Radolf J.D., Fikrig E. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol. Microbiol. 2007, 63:694-710.
31. Long M., Luo J., Li Y., Zeng F.Y., Li M. Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer. World J. Gastroenterol. 2009, 15:2381-2388.
32. Luzza F., Parrello T., Monteleone G., Sebkova L., Romano M., Zarrilli R., Imeneo M., Pallone F. Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 2000, 165:5332-5337.
33. Malfertheiner P., Schultze V., Rosenkranz B., Kaufmann S.H., Ulrichs T., Novicki D., Norelli F., Contorni M., Peppoloni S., Berti D., Tornese D., Ganju J., Palla E., Rappuoli R., Scharschmidt B.F., Del Giudice G. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology 2008, 135:787-795.
34. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 1997, 91:385-395.
35. Montecucco C., Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat. Rev. Mol. Cell Biol. 2001, 2:457-466.
36. Montemurro P., Barbuti G., Dundon W.G., Del Giudice G., Rappuoli R., Colucci M., De Rinaldis P., Montecucco C., Semeraro N., Papini E. Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J. Infect. Dis. 2001, 183:1055-1062.
37. Montemurro P., Nishioka H., Dundon W.G., de Bernard M., Del Giudice G., Rappuoli R., Montecucco C. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur. J. Immunol. 2002, 32:671-676.
38. Mosmann T.R., Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 1989, 46:111-147.
39. Nishioka H., Basso I., Semenzato G., Trentin L., Rappuoli R., Del Giudice G., Montecucco C. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) activates the MAPK pathway in human neutrophils. Eur. J. Immunol. 2003, 33:840-849.
40. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
41. Papinutto E., Dundon W.G., Pitulis N., Battistutta R., Montecucco C., Zanotti G. Structure of two iron-binding proteins from Bacillus anthracis. J. Biol. Chem. 2002, 277:15093-15098.
42. Polenghi A., Bossi F., Fischetti F., Durigutto P., Cabrelle A., Tamassia N., Cassatella M.A., Montecucco C., Tedesco F., de Bernard M. The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J. Immunol. 2007, 178:1312-1320.
43. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 2000, 85:9-18.
44. 2+. FEBS Lett. 1985, 181:253-258.
45. Satin B., Del Giudice G., Della Bianca V., Dusi S., Laudanna C., Tonello F., Kelleher D., Rappuoli R., Montecucco C., Rossi F. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 2000, 191:1467-1476.
46. Silverstein R., Wood J.G., Xue Q., Norimatsu M., Horn D.L., Morrison D.C. Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis. Infect. Immun. 2000, 68:2301-2308.
47. Sun B., Li Z.S., Tu Z.X., Xu G.M., Du Y.Q. Construction of an oral recombinant DNA vaccine from H. pylori neutrophil activating protein and its immunogenicity. World J. Gastroenterol. 2006, 12:7042-7046.
48. Thelen M., Dewald B., Baggiolini M. Neutrophil signal transduction and activation of the respiratory burst. Physiol. Rev. 1993, 73:797-821.
49. Tomita T., Jackson A.M., Hida N., Hayat M., Dixon M.F., Shimoyama T., Axon A.T., Robinson P.A., Crabtree J.E. Expression of Interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J. Infect. Dis. 2001, 183:620-627.
50. Tonello F., Dundon W.G., Satin B., Molinari M., Tognon G., Grandi G., Del Giudice G., Rappuoli R., Montecucco C. The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure. Mol. Microbiol. 1999, 34:238-246.
51. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
52. Unemo M., Aspholm-Hurtig M., Ilver D., Bergström J., Borén T., Danielsson D., Teneberg S. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. J. Biol. Chem. 2005, 280:15390-15397.
53. Wang G., Hong Y., Olczak A., Maier S.E., Maier R.J. Dual roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect. Immun. 2006, 74:6839-6846.
54. Wang C.A., Liu Y.C., Du S.Y., Lin C.W., Fu H.W. Helicobacter pylori neutrophil-activating protein promotes myeloperoxidase release from human neutrophils. Biochem. Biophys. Res. Commun. 2008, 377:52-56.
55. Zanotti G., Papinutto E., Dundon W.G., Battistutta R., Seveso M., Del Giudice G., Rappuoli R., Montecucco C. Structure of the neutrophil-activating protein from Helicobacter pylori. J. Mol. Biol. 2002, 323:125-130.